PCH
Polar Capital Holdings Portfolio holdings
AUM
$21.9B
1-Year Est. Return
83.22%
This Fund
S&P 500
1 Year Est. Return
+83.22%
AUM
$21.9B
AUM Growth
+$1.14B
(+5.5%)
Holding
300
Top Buys
| 1 | +$208M | |
| 2 | +$193M | |
| 3 | +$183M | |
| 4 |
Eli Lilly
LLY
|
+$175M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$157M |
Top Sells
| 1 | +$359M | |
| 2 | +$253M | |
| 3 | +$183M | |
| 4 |
Micron Technology
MU
|
+$165M |
| 5 |
Corning
GLW
|
+$149M |
Sector Composition
| 1 | Technology | 50.1% |
| 2 | Healthcare | 17.29% |
| 3 | Financials | 14.82% |
| 4 | Communication Services | 8.48% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
CG Oncology
CGON
$4.84B
| $45.6M | 0.21% |
1,098,662
|
|
||
102
Neuropace
NPCE
$472M
| $44.4M | 0.2% |
2,878,523
-219,345
|
|
||
103
RLI Corp
RLI
$5.77B
| $44M | 0.2% |
687,500
+152,500
|
|
||
104
Taysha Gene Therapies
TSHA
$1.25B
| $43.6M | 0.2% |
7,931,403
+2,637,524
|
|
||
105
MakeMyTrip
MMYT
$5.28B
| $42.7M | 0.2% |
519,857
+156,029
|
|
||
106
Insulet
PODD
$17.3B
| $42.2M | 0.19% |
148,299
+88,982
|
|
||
107
Dianthus Therapeutics
DNTH
$2.39B
| $41.4M | 0.19% |
1,004,728
+256,725
|
|
||
108
Walmart Inc
WMT
$1.02T
| $40.8M | 0.19% |
366,034
+39,406
|
|
||
109
Stoke Therapeutics
STOK
$2.14B
| $40.3M | 0.18% |
1,269,131
-54,339
|
|
||
110
Cognizant
CTSH
$30.5B
| $40M | 0.18% |
+482,096
|
|
||
|
ZBIO
111
Zenas BioPharma
ZBIO
$1.38B
| $38.4M | 0.18% |
+1,057,609
|
|
||
112
Apogee Therapeutics
APGE
$4.89B
| $38M | 0.17% |
503,539
-20,555
|
|
||
113
IQVIA
IQV
$29.7B
| $36M | 0.16% |
159,543
+83,584
|
|
||
114
Thermo Fisher Scientific
TMO
$191B
| $35.4M | 0.16% |
61,164
+4,340
|
|
||
115
JPMorgan Chase
JPM
$803B
| $35.4M | 0.16% |
109,733
-5,888
|
|
||
|
BOW
116
Bowhead Specialty Holdings
BOW
$843M
| $35M | 0.16% |
1,225,000
+535,065
|
|
||
117
Intercontinental Exchange
ICE
$93.7B
| $34.9M | 0.16% |
215,430
-270
|
|
||
118
US Foods
USFD
$21.1B
| $34.5M | 0.16% |
458,296
+69,504
|
|
||
119
Olema Pharmaceuticals
OLMA
$1.92B
| $34.5M | 0.16% |
+1,380,450
|
|
||
120
JFrog
FROG
$4.96B
| $34.3M | 0.16% |
548,383
+18,547
|
|
||
121
First American
FAF
$7.16B
| $33.2M | 0.15% |
540,000
-135,000
|
|
||
122
Affiliated Managers Group
AMG
$8.35B
| $30.9M | 0.14% |
107,245
+28,722
|
|
||
123
Affirm
AFRM
$15.6B
| $30.6M | 0.14% |
411,776
+10,195
|
|
||
124
Johnson Controls International
JCI
$88.8B
| $30.5M | 0.14% |
254,632
+141,008
|
|
||
|
RAPP
125
Rapport Therapeutics
RAPP
$1.35B
| $30.5M | 0.14% |
1,004,728
+65,776
|
|